Multi-Cancer Detection Observational Cohort Study
Mayo Clinic
500 participants
May 7, 2025
OBSERVATIONAL
Conditions
Summary
This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.
Eligibility
Inclusion Criteria5
- Has Mayo Clinic medical record number
- Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider
- Able to provide informed consent
- ≥ 21 years old
- Ability to provide blood sample
Exclusion Criteria5
- Individuals who have situations that would limit compliance with the study requirements
- Institutionalized (i.e. Federal Medical Prison)
- Known pregnancy (self-reported)
- Currently undergoing active cancer treatment other than adjuvant hormone therapy
- Invasive cancer diagnosis within the last 3 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Up to 60 mL (about 4-5 Tbsp) of blood may be collected for an initial blood draw and up to 30 mL (about 2-3 Tbsp) may be collected for a second blood draw, 25-45 days after first blood draw. The research blood will be collected at the time of a clinical blood draw, if possible.
Participants will complete surveys related to attitudes and beliefs around Multi-Cancer Detection testing.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06962995